New Delhi metallo-β-lactamase-1: Detection and prevention

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 11, 2011, Pages 1240-1241

  Walsh, Timothy R ^a,b  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIN; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; TIGECYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COMMUNITY; ENZYME ANALYSIS; ESCHERICHIA COLI; GENE TRANSFER; HOSPITAL; HUMAN; INDIA; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; NDM 1 GENE; NONHUMAN; NOTE; PLASMID; PROVIDENCIA RETTGERI; SANITATION; URINALYSIS; URINARY TRACT INFECTION;

EID: 80051573603     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.111100     Document Type: Note

References (10)

1. Deshpande P, Rodrigues C, Shetty A, et al. New Delhi Metallo- β-lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J Assoc Physicians India 2010; 58:147-9.
2. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo- β-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046-54.
3. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597-602.
4. Walsh TR, Toleman MA. The new medical challenge: why NDM-1? Why Indian? Expert Rev Anti Infect Ther 2011;9:137-41.
5. Walsh TR, Weeks J, Livermore DM, et al. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011;11:355-62.
6. Nordmann P, Poirel L, Carrer A, et al. How to detect NDM-1 producers. J Clin Microbiol 2011;49:718-21.
7. Kus JV, Tadros M, Simor A, et al. New Delhi metallo-β-lactamase- 1: local acquisition in Ontario, Canada, and challenges in detection. CMAJ 2011;183:1257-61.
8. Bhaskar E. New Delhi metallo-β-lactamase 1. Lancet Infect Dis. 2010, 10:749; author reply 752-744.
9. Sirohi B. New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010; 10:750, author reply 752-4.
10. Poirel L, Hombrouck-Alet C, Freneaux C, et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010; 10: 832.